Literature DB >> 2155598

Heterotypic and homotypic re-inoculation of mice already latently infected with herpes simplex virus type 1.

D L Yirrell1, W A Blyth, T J Hill, C E Rogers.   

Abstract

Mice were infected at 4 weeks of age with a type 1 strain of herpes simplex virus (HSV) and re-infected 4 weeks later with either a type 1 or a type 2 strain of HSV. The virus used for first infection could be distinguished from that used later since it was resistant to phosphonoformic acid and formed syncytial plaques. Sites used for the second inoculation were as follows: at the site of primary infection, at a different site within the same dermatome or in the equivalent dermatome on the opposite side (also called "remote" site). Re-infection caused no detectable reactivation of the latent PFA resistant virus. After re-infection with a homotypic virus replication of the re-infecting virus was limited to the inoculation site. However after heterotypic re-infection the type 2 strain was occasionally isolated from the ganglia. Previous infection with the PFA resistant type 1 strain clearly reduced the ability of the homotypic or heterotypic strains to establish a latent infection. However, in a few animals ganglia were found to be latently infected with virus from both the first and second inoculations. Analysis of the results suggests that resistance to the establishment of a second latent infection in a ganglion is determined by the general immunity of the animal rather than "immunity" of the latently infected ganglion itself.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2155598     DOI: 10.1007/BF01310700

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  14 in total

1.  Experimental in vivo generation of intertypic recombinant strains of HSV in the mouse.

Authors:  D L Yirrell; C E Rogers; W A Blyth; T J Hill
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

Review 2.  Problems of herpes simplex virus latency.

Authors:  R J Klein
Journal:  Antiviral Res       Date:  1985       Impact factor: 5.970

3.  Experimental human reinfection with herpes simplex virus.

Authors:  H Blank; H G Haines
Journal:  J Invest Dermatol       Date:  1973-10       Impact factor: 8.551

4.  Pathogenesis of zosteriform spread of herpes simplex virus in the mouse.

Authors:  W A Blyth; D A Harbour; T J Hill
Journal:  J Gen Virol       Date:  1984-09       Impact factor: 3.891

5.  Spread of virus and distribution of latent infection following ocular herpes simplex in the non-immune and immune mouse.

Authors:  A B Tullo; C Shimeld; W A Blyth; T J Hill; D L Easty
Journal:  J Gen Virol       Date:  1982-11       Impact factor: 3.891

6.  Effects of adenosine monophosphate on the reactivation of latent herpes simplex virus type 1 infections of mice.

Authors:  W T Blue; R D Winland; D G Stobbs; D F Kirksey; R E Savage
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191

7.  Retrieval of latent herpes simplex virus type 1 genetic information from murine trigeminal ganglia by superinfection with heterotypic virus in vivo.

Authors:  E Thomas; E Lycke; A Vahlne
Journal:  J Gen Virol       Date:  1985-08       Impact factor: 3.891

8.  Recurrence phenotypes and establishment of latency following rabbit keratitis produced by multiple herpes simplex virus strains.

Authors:  J C Gerdes; D S Smith
Journal:  J Gen Virol       Date:  1983-11       Impact factor: 3.891

9.  Recurrent herpes simplex in the mouse: inflammation in the skin and activation of virus in the ganglia following peripheral stimulation.

Authors:  D A Harbour; T J Hill; W A Blyth
Journal:  J Gen Virol       Date:  1983-07       Impact factor: 3.891

10.  Colonization of murine ganglia by a superinfecting strain of herpes simplex virus.

Authors:  B Meignier; B Norrild; B Roizman
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

View more
  2 in total

1.  Experimental in vivo generation of intertypic recombinant strains of HSV in the mouse.

Authors:  D L Yirrell; C E Rogers; W A Blyth; T J Hill
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  Latency and reactivation of infectious laryngotracheitis vaccine virus.

Authors:  C S Hughes; R A Williams; R M Gaskell; F T Jordan; J M Bradbury; M Bennett; R C Jones
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.